Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Ambu A/S (CPH:AMBU B), is not the largest company out there, but it saw significant share price movement during recent months on the CPSE, rising to highs of kr.121 and falling to the lows of kr.91.65. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Ambu's current trading price of kr.96.25 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Ambu’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

Advertisement

What Is Ambu Worth?

Good news, investors! Ambu is still a bargain right now. Our valuation model shows that the intrinsic value for the stock is DKK137.52, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. However, given that Ambu’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

Check out our latest analysis for Ambu

What kind of growth will Ambu generate?

earnings-and-revenue-growth
CPSE:AMBU B Earnings and Revenue Growth July 12th 2025

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Ambu's earnings over the next few years are expected to double, indicating a very optimistic future ahead. This should lead to stronger cash flows, feeding into a higher share value.

What This Means For You

Are you a shareholder? Since AMBU B is currently undervalued, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

Are you a potential investor? If you’ve been keeping an eye on AMBU B for a while, now might be the time to make a leap. Its buoyant future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy AMBU B. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

If you'd like to know more about Ambu as a business, it's important to be aware of any risks it's facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Ambu.

If you are no longer interested in Ambu, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About CPSE:AMBU B

Ambu

Researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally.

Flawless balance sheet with solid track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0771.8% undervalued
274 users have followed this narrative
1 users have commented on this narrative
37 users have liked this narrative
GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.5% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
TO
Tokyo
ABI logo
Tokyo on Anheuser-Busch InBev ·

EU#8 - Anheuser-Busch InBev: Courage, Capital, and the Discipline to Build an Empire

Fair Value:€89.4522.8% undervalued
1 users have followed this narrative
2 users have commented on this narrative
1 users have liked this narrative
OS
oscargarcia
AMZN logo
oscargarcia on Amazon.com ·

The capitalist colossus that makes your parcels magically appear, powers half the internet, and knows your shopping habits.

Fair Value:US$2802.8% undervalued
56 users have followed this narrative
1 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

CO
Coward_Nutlick
ELTX logo
Coward_Nutlick on Elicio Therapeutics ·

Very Bullish

Fair Value:US$10089.2% undervalued
20 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
HedgeY
PWR logo
HedgeY on Quanta Services ·

The Picks-and-Shovels Leader of the Grid Supercycle

Fair Value:US$7106.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MR
MRT23
FISV logo
MRT23 on Fiserv ·

Q1 2026 FCF collapse has reset the debate from "fair value" to "distressed transformation"

Fair Value:US$8526.1% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.235.0% undervalued
68 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$561.9326.4% undervalued
1394 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74017.5% undervalued
31 users have followed this narrative
3 users have commented on this narrative
32 users have liked this narrative

Trending Discussion